Point-of-Care Diagnostics Market Size and Forecast (2025–2033)

The Point-of-Care (POC) Diagnostics Market is entering a new era of expansion and innovation, driven by global shifts in healthcare demand, technological breakthroughs, and the growing need for rapid, decentralized testing. According to Renub Research, the global Point-of-Care Diagnostics market is projected to surge to US$ 105.22 billion by 2033, rising from US$ 50.08 billion in 2024. This reflects an impressive CAGR of 8.60% between 2025 and 2033, showcasing the widespread adoption of convenient, real-time diagnostic solutions.

POC diagnostics—once limited to basic tests—have evolved into sophisticated tools capable of detecting infectious diseases, metabolic disorders, cardiac markers, and much more, all within minutes and without centralized laboratory involvement. This shift is transforming patient care by reducing delays, optimizing treatment pathways, and promoting self-monitoring.

Download Free Sample Report

Understanding the Role of Point-of-Care Diagnostics in Modern Healthcare

Point-of-care diagnostics deliver rapid medical test results directly at the site of patient care, whether in clinics, emergency rooms, pharmacies, workplaces, or even homes. This decentralized approach drastically shortens the time from diagnosis to treatment, improving outcomes and easing healthcare system burdens.

These devices support a wide range of applications, including:

Glucose monitoring for diabetes

Infectious disease testing for COVID-19, HIV, influenza

Pregnancy and fertility assessments

Cardiac marker analysis

Urinalysis, lipid testing, and drug-abuse detection

In emergency and critical care settings, POC tools can even determine blood gases and electrolytes within moments, enabling life-saving decisions.

POC diagnostics are increasingly indispensable for personalized medicine, home-based care, and managing chronic diseases—key themes driving this market’s momentum.

Market Snapshot

Report Features Details

Base Year 2024

Forecast Years 2025–2033

Historical Years 2020–2024

Market Size (2024) US$ 50.08 Billion

Market Size (2033) US$ 105.22 Billion

CAGR (2025–2033) 8.60%

Key Growth Drivers for the Global Point-of-Care Diagnostics Market

1. Accelerated Technological Innovation

Technological advancements lie at the heart of POC diagnostics growth. Miniaturization, lab-on-a-chip systems, advanced biosensors, automation, and AI integration are revolutionizing test accuracy, speed, and usability.

Next-generation devices are now capable of performing multiple tests simultaneously, reducing the need for lab infrastructure while increasing diagnostic coverage. Companies are racing to develop compact yet powerful devices capable of delivering hospital-grade accuracy.

A notable example occurred in 2023, when Molbio Diagnostics partnered with SigTuple to develop AI-driven portable diagnostic tools that offer routine and specialized screening. Moves like these signal a future where smart diagnostics redefine healthcare delivery.

2. Rising Demand for Personalized and Precision Medicine

The global shift toward patient-specific treatment plans is fueling the adoption of POC diagnostics. Rapid, tailored testing enables clinicians to create treatment strategies that match a patient’s biological profile.

The National Cancer Institute’s large-scale precision oncology initiative exemplifies the momentum toward personalized therapies. Studies from Coriell Life Sciences show that precision medicine has reached a global adoption tipping point—further reinforcing the need for POC technologies that give immediate, actionable health insights.

3. Increasing Burden of Chronic Diseases

Chronic diseases are a massive driver of POC diagnostic growth. The WHO reports that 41 million people die each year from non-communicable diseases, accounting for 74% of global deaths.

Conditions such as:

Diabetes

Cardiovascular diseases

Respiratory illnesses

Kidney disorders

require ongoing monitoring that POC devices are uniquely suited to provide.

POC tools offer real-time results in rural and underserved regions where lab facilities are scarce, making them vital in improving global health equity.

4. Growing Consumer Preference for Home-Based Testing

Modern consumers prefer convenient, cost-effective, and privacy-centered health solutions. This has driven a surge in OTC diagnostic kits for fertility, infectious disease detection, glucose monitoring, and more.

As healthcare systems emphasize early detection and preventive care, home-based POC diagnostics are becoming central to routine health management.

Challenges Facing the Point-of-Care Diagnostics Market

1. Accuracy Limitations Among Certain Tests

Despite advancements, some POC kits still lack the precision of laboratory testing. Variability in sample collection, device handling, or environmental conditions can compromise results.

High costs associated with advanced POC technologies also hinder widespread adoption, especially in lower-income regions.

2. Regulatory and Quality Assurance Barriers

Achieving uniform regulatory standards is a significant challenge. Low-resource settings often lack:

Skilled personnel

Proper calibration tools

Robust quality-control systems

This may lead to inconsistent test results and slow adoption rates. Additionally, frequent updates in regulatory frameworks require constant product modification and recertification.

Market Insights by Product Category

1. Glucose Monitoring Kits: Dominant Segment

The prevalence of diabetes—impacting 38.4 million Americans as of the CDC’s 2021 data—has propelled glucose monitoring kits to the top of the POC market.

Their importance lies in:

Daily self-management

Early complication detection

Integration with wearable and digital health tools

This segment is expected to maintain strong dominance.

2. Lateral Flow Technology: Leading the Market

Lateral flow tests (LFTs) deliver fast, simple, and equipment-free results, making them indispensable for:

Pregnancy testing

COVID-19 and influenza detection

Drug testing

They remain the most accessible and scalable POC technology worldwide.

3. OTC Devices: Major Growth Catalyst

OTC-based POC devices support healthcare democratization by empowering individuals to monitor health independently. Rising self-awareness and a shift toward preventive care contribute to the segment’s rapid expansion.

4. Professional Diagnostic Centers: Key End Users

While home-based kits are booming, professional diagnostic centers remain vital users of POC devices due to their:

Technical expertise

Capacity for complex testing

Higher accuracy and reliability

These centers bridge the gap between rapid diagnostics and clinical interpretation.

Regional Analysis: Market Breakdown by Geography

United States: The Global Leader

The US dominates the POC diagnostics market, driven by:

High chronic disease prevalence

Heavy investment in advanced healthcare technology

Expanding demand for fast and convenient testing

The market strengthens further when regulatory bodies approve new devices. For instance, in May 2022, the USFDA approved the ADEXUSDx hCG Test by NOWDiagnostics for early pregnancy screening in diverse clinical settings.

Challenges in reimbursement and healthcare data integration remain but do not hinder the market’s strong upward trajectory.

Germany: A European Stronghold

Germany benefits from:

An aging population

A technologically advanced healthcare system

High adoption of home-testing kits

The country’s focus on preventative care fuels POC demand, although regulatory and reimbursement complexities can moderate growth.

India: Fastest-Growing POC Market in Asia

India’s POC diagnostics market is accelerating due to:

A large population with unmet medical needs

Rising chronic disease cases

Healthcare expansion in rural regions

Initiatives such as Cipla’s launch of "Cippoint" in January 2023—a multifunction POC testing platform—highlight how domestic innovation is reshaping diagnostics accessibility.

Saudi Arabia: Rapid Adoption Aligned with Vision 2030

Saudi Arabia’s healthcare modernization efforts are expanding the POC diagnostics landscape. Key contributing factors include:

Strong government investment

Rising rates of diabetes and heart disease

Growing acceptance of home-based testing

The country is poised for continued adoption, despite ongoing regulatory challenges.

Market Segmentation Overview

Products (9 Categories)

Glucose Monitoring Kits

Infectious Diseases Kits

Pregnancy & Fertility Testing Kits

Haematology Testing Kits

Cardiometabolic Monitoring Kits

Urinalysis Testing Kits

Cholesterol Test Strips

Drugs Abuses Testing Kits

Others

Technology (6 Categories)

Lateral Flow

Agitation

Flow Through

Solid Phase

Biosensor

Others

Point of Prescription (2 Segments)

Prescription-Based Devices

Over-the-counter (OTC) Devices

End Users (4 Segments)

Professional Diagnostic Centers

Research Laboratories

Home Care

Others

Countries Covered (25 markets across 5 regions)

North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Key Companies Profiled

Sysmex

Abbott Laboratories (US)

Becton Dickinson and Company (US)

Danaher Corporation (US)

Quidel Diagnostics (US)

F. Hoffmann-La Roche Ltd

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories Inc.

These companies lead through innovation, strategic collaborations, and diversified product portfolios.

Final Thoughts

The Point-of-Care Diagnostics market is at the forefront of healthcare innovation, reshaping how individuals and professionals access and utilize medical testing. With its ability to provide swift, accurate, and decentralized results, POC diagnostics will remain central to the future of global healthcare.

As technological advancements—especially AI, biosensors, and miniaturization—converge with rising consumer expectations and chronic disease prevalence, this market is poised for sustained growth through 2033 and beyond.

POC diagnostics are not just tools; they represent a transformative shift toward faster care, empowered patients, and more resilient healthcare systems.